A study to evaluate the impact of test food ingestion on cerebral blood flow

Not Applicable

• Conditions: Healthy people

• Registration Number: JPRN-UMIN000035521
• Lead Sponsor: KT Medical Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects with current medical history and history of serious disorders that influence this study 2.Subjects with surgical history of head or foreign metal in their head 3.Subjects who are under hormone treatment, or who have been diagnosed as climacterium 4.Subjects with history of heart disease or heart pacemakers 5.Subjects with pollen allergy 6.Subjects with difficulty of color discrimination 7.Subjects whose visual or hearing acuity is too low to perform tests, or who have been diagnosed as amblyopia, blindness, or deafness 8.Subjects who may have physical deconditioning due to test foods 9.Subjects who have diseases requiring regular administration, or who have anamnesis of severe diseases 10.Subjects who are under treatment for brain function, or who regularly intake drugs or health foods that influence brain function more than once a week 11.Subjects who regularly intake drugs or health foods that influence cerebral blood flow more than once a week 12.Subjects who regularly intake foods resembling test food or energy drink more than once a week 13.Subjects who are, or are planning to be pregnant or nursing during study 14.Subjects who sometimes have irregular lifestyles during study 15.Subjects who regularly drink alcohol beyond proper quantity 16.Smokers, or subjects who initiated smoking cessation within 12 months 17.Subjects who undergo brain function tests within 12 months 18.Subjects who make 200 mL or 400 mL blood donation within 3 months 19.Subjects who are participating in other clinical trials within 1 month or who are planning to participate in other clinical trials during study 20.Subjects who are suspected of dementia 21.Subjects considered to be unsuitable for enrollment based on lifestyle questionnaire or cerebral blood flow measurement 22.Subjects who work in a company developing functional foods 23.Subjects who are judged as unsuitable by doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified